Asma Yousafzai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Asma Yousafzai has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Abdul Majeed Khan
General Studies Department, Jubail Industrial College, Jubail Industrial City 31961, Saudi Arabia
1 shared publication- Asma Abro
Department of Biotechnology, BUITEMS, Takatu Campus, Quetta, Pakistan
1 shared publication - Hamid Ullah
Chemistry BUITEMS Quetta Pakistan
1 shared publication - Mahmood Rasool
Institute of Genomic Medicine Sciences (IGMS), King Abdulaziz University, Jeddah, Saudi Arabia
1 shared publication - Mehboob Ahmed
Department of Biotechnology, BUITEMS, Takatu Campus, Quetta, Pakistan
1 shared publication Muhammad Asif
Department of Biotechnology & ORIC, BUITEMS, Takatu Campus, Quetta, Pakistan
1 shared publication
Latest Publications
- Open Access
- 31 May 2024
- Published by Biomedical Informatics in Bioinformation
- Vol. 20 (5) , 449-459
Synthesis and molecular docking analysis of MBH adducts' derived amides as potential β-lactamase inhibitors
Humans suffer from various diseases that require more specific drugs to target them. Among the different potent agents, β-lactamases serve as good antibacterial agents; however, β-lactamases are resistant to such antibiotics. The present study was designed to prepare efficient β-lactamase inhibitor amides (12-15) from inexpensive, easily accessible, and bioactive precursors; Morita Baylis Hillman (MBH) adducts (5-8). The adducts (5-8) were primarily prepared by treating their respective aldehydes with the corresponding acrylate in the presence of an organic Lewis base at ambient temperature. The compounds were characterized using mass spectrometry, FTIR and NMR spectroscopy. Furthermore, in silico studies (using AutoDock Tools and AutoDock Vina programs) on the adduct and corresponding amide product revealed that all MBH adducts (5-8) and their product amides (12-15) are significant inhibitors of β-lactamase. Additionally, among the MBH adducts, adduct 7 showed the highest binding affinity with β-lactamase, whereas amide 15 was identified as a highly potent antibacterial based on its docking score (-8.6). In addition, the absorption, distribution, metabolism, and excretion (ADME) test of the synthesized compounds demonstrated that all compounds showed drug-likeness properties.
- 31 May 2024
- Published by Biomedical Informatics in Bioinformation
- Vol. 20 (5) , 449-459
Open AccessSynthesis and molecular docking analysis of MBH adducts' derived amides as potential β-lactamase inhibitors
Humans suffer from various diseases that require more specific drugs to target them. Among the different potent agents, β-lactamases serve as good antibacterial agents; however, β-lactamases are resistant to such antibiotics. The present study was designed to prepare efficient β-lactamase inhibitor amides (12-15) from inexpensive, easily accessible, and bioactive precursors; Morita Baylis Hillman (MBH) adducts (5-8). The adducts (5-8) were primarily prepared by treating their respective aldehydes with the corresponding acrylate in the presence of an organic Lewis base at ambient temperature. The compounds were characterized using mass spectrometry, FTIR and NMR spectroscopy. Furthermore, in silico studies (using AutoDock Tools and AutoDock Vina programs) on the adduct and corresponding amide product revealed that all MBH adducts (5-8) and their product amides (12-15) are significant inhibitors of β-lactamase. Additionally, among the MBH adducts, adduct 7 showed the highest binding affinity with β-lactamase, whereas amide 15 was identified as a highly potent antibacterial based on its docking score (-8.6). In addition, the absorption, distribution, metabolism, and excretion (ADME) test of the synthesized compounds demonstrated that all compounds showed drug-likeness properties.